AdaptHealth (AHCO) Competitors

$10.74 -0.07 (-0.65%)

Closing price 04:00 PM Eastern

Extended Trading

$10.74 +0.00 (+0.05%)

As of 04:45 PM Eastern

AHCO vs. PACS, CAI, RDNT, SHC, and BLLN

Should you buy AdaptHealth stock or one of its competitors? MarketBeat compares AdaptHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AdaptHealth include PACS Group (PACS), Caris Life Sciences (CAI), RadNet (RDNT), Sotera Health (SHC), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does AdaptHealth compare to PACS Group?

PACS Group (NYSE:PACS) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, AdaptHealth had 1 more articles in the media than PACS Group. MarketBeat recorded 14 mentions for AdaptHealth and 13 mentions for PACS Group. PACS Group's average media sentiment score of 1.06 beat AdaptHealth's score of 0.68 indicating that PACS Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	6 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdaptHealth	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.43B	1.16	$191.54M	$1.56	25.46
AdaptHealth	$3.28B	0.45	-$70.79M	-$0.62	N/A

82.7% of AdaptHealth shares are held by institutional investors. 70.1% of PACS Group shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

PACS Group currently has a consensus price target of $45.60, indicating a potential upside of 14.80%. AdaptHealth has a consensus price target of $14.29, indicating a potential upside of 33.01%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

PACS Group has a net margin of 4.49% compared to AdaptHealth's net margin of -2.42%. PACS Group's return on equity of 26.47% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
AdaptHealth	-2.42%	2.76%	0.99%

PACS Group has a beta of -0.03, meaning that its share price is 103% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

Summary

PACS Group beats AdaptHealth on 12 of the 17 factors compared between the two stocks.

How does AdaptHealth compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and AdaptHealth (NASDAQ:AHCO) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, Caris Life Sciences had 9 more articles in the media than AdaptHealth. MarketBeat recorded 23 mentions for Caris Life Sciences and 14 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.68 beat Caris Life Sciences' score of 0.16 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	6 Negative mention(s)	1 Very Negative mention(s)	Neutral
AdaptHealth	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Caris Life Sciences has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.31	-$68.09M	-$7.61	N/A
AdaptHealth	$3.28B	0.45	-$70.79M	-$0.62	N/A

Caris Life Sciences has a net margin of 3.75% compared to AdaptHealth's net margin of -2.42%. Caris Life Sciences' return on equity of 98.28% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
AdaptHealth	-2.42%	2.76%	0.99%

Caris Life Sciences currently has a consensus price target of $27.56, indicating a potential upside of 80.69%. AdaptHealth has a consensus price target of $14.29, indicating a potential upside of 33.01%. Given Caris Life Sciences' higher possible upside, research analysts plainly believe Caris Life Sciences is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

82.7% of AdaptHealth shares are held by institutional investors. 7.8% of Caris Life Sciences shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Caris Life Sciences beats AdaptHealth on 10 of the 14 factors compared between the two stocks.

How does AdaptHealth compare to RadNet?

RadNet (NASDAQ:RDNT) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

RadNet currently has a consensus target price of $88.14, indicating a potential upside of 64.97%. AdaptHealth has a consensus target price of $14.29, indicating a potential upside of 33.01%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts clearly believe RadNet is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, AdaptHealth had 1 more articles in the media than RadNet. MarketBeat recorded 14 mentions for AdaptHealth and 13 mentions for RadNet. AdaptHealth's average media sentiment score of 0.68 beat RadNet's score of 0.31 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a net margin of -0.66% compared to AdaptHealth's net margin of -2.42%. RadNet's return on equity of 2.77% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
AdaptHealth	-2.42%	2.76%	0.99%

77.9% of RadNet shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 2.0% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

RadNet has higher earnings, but lower revenue than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.06	-$18.65M	-$0.18	N/A
AdaptHealth	$3.28B	0.45	-$70.79M	-$0.62	N/A

RadNet has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

Summary

RadNet beats AdaptHealth on 10 of the 17 factors compared between the two stocks.

How does AdaptHealth compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

In the previous week, AdaptHealth had 8 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for AdaptHealth and 6 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.79 beat AdaptHealth's score of 0.68 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdaptHealth	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 2.0% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sotera Health has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.80	$77.94M	$0.41	37.78
AdaptHealth	$3.28B	0.45	-$70.79M	-$0.62	N/A

Sotera Health currently has a consensus target price of $20.33, indicating a potential upside of 31.27%. AdaptHealth has a consensus target price of $14.29, indicating a potential upside of 33.01%. Given AdaptHealth's higher possible upside, analysts clearly believe AdaptHealth is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Sotera Health has a net margin of 9.91% compared to AdaptHealth's net margin of -2.42%. Sotera Health's return on equity of 39.73% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
AdaptHealth	-2.42%	2.76%	0.99%

Sotera Health has a beta of 1.82, indicating that its share price is 82% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

Summary

Sotera Health beats AdaptHealth on 13 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and AdaptHealth (NASDAQ:AHCO) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Billiontoone currently has a consensus target price of $125.29, suggesting a potential upside of 42.47%. AdaptHealth has a consensus target price of $14.29, suggesting a potential upside of 33.01%. Given Billiontoone's higher possible upside, research analysts clearly believe Billiontoone is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has a net margin of 0.00% compared to AdaptHealth's net margin of -2.42%. AdaptHealth's return on equity of 2.76% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
AdaptHealth	-2.42%	2.76%	0.99%

82.7% of AdaptHealth shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Billiontoone has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	11.40	$7.45M	$0.55	159.89
AdaptHealth	$3.28B	0.45	-$70.79M	-$0.62	N/A

In the previous week, AdaptHealth had 9 more articles in the media than Billiontoone. MarketBeat recorded 14 mentions for AdaptHealth and 5 mentions for Billiontoone. AdaptHealth's average media sentiment score of 0.68 beat Billiontoone's score of 0.55 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdaptHealth	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Billiontoone and AdaptHealth tied by winning 7 of the 14 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AHCO vs. The Competition

Export

Metric	AdaptHealth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.46B	$8.00B	$6.29B	$12.46B
Dividend Yield	N/A	2.50%	2.79%	5.30%
P/E Ratio	-17.32	18.40	20.89	25.59
Price / Sales	0.45	7.69	523.74	63.24
Price / Cash	2.69	16.76	42.94	55.34
Price / Book	0.96	3.68	9.86	6.70
Net Income	-$70.79M	$223.05M	$3.55B	$333.77M
7 Day Performance	-8.44%	-2.01%	-0.33%	0.45%
1 Month Performance	-15.90%	3.52%	1.34%	4.06%
1 Year Performance	20.67%	2.04%	41.10%	36.24%

AdaptHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AHCO AdaptHealth	4.8935 of 5 stars	$10.74 -0.6%	$14.29 +33.0%	+19.8%	$1.46B	$3.28B	N/A	10,900	Analyst Forecast Gap Down
PACS PACS Group	3.6207 of 5 stars	$32.06 -4.6%	$44.40 +38.5%	+277.1%	$5.28B	$5.29B	26.06	47,455	Positive News Earnings Report Analyst Forecast
CAI Caris Life Sciences	4.3621 of 5 stars	$15.94 -1.3%	$27.56 +72.9%	N/A	$4.56B	$812.03M	N/A	1,846	Analyst Upgrade Insider Trade
RDNT RadNet	3.2325 of 5 stars	$55.90 -3.9%	$88.14 +57.7%	-12.5%	$4.55B	$2.04B	N/A	11,264	Earnings Report Analyst Downgrade Gap Up High Trading Volume
SHC Sotera Health	3.9243 of 5 stars	$15.43 -2.2%	$20.33 +31.8%	+16.9%	$4.50B	$1.19B	37.64	3,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AHCO) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AdaptHealth (AHCO) Competitors

AHCO vs. PACS, CAI, RDNT, SHC, and BLLN

How does AdaptHealth compare to PACS Group?

Summary

How does AdaptHealth compare to Caris Life Sciences?

Summary

How does AdaptHealth compare to RadNet?

Summary

How does AdaptHealth compare to Sotera Health?

Summary

How does AdaptHealth compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AdaptHealth (AHCO) Competitors

AHCO vs. PACS, CAI, RDNT, SHC, and BLLN

How does AdaptHealth compare to PACS Group?

Does the media refer more to PACS or AHCO?

Which has stronger valuation and earnings, PACS or AHCO?

Do institutionals and insiders believe in PACS or AHCO?

Do analysts rate PACS or AHCO?

Is PACS or AHCO more profitable?

Which has more volatility and risk, PACS or AHCO?

Summary

How does AdaptHealth compare to Caris Life Sciences?

Does the media favor CAI or AHCO?

Which has stronger valuation and earnings, CAI or AHCO?

Is CAI or AHCO more profitable?

Do analysts rate CAI or AHCO?

Do institutionals and insiders believe in CAI or AHCO?

Summary

How does AdaptHealth compare to RadNet?

Do analysts rate RDNT or AHCO?

Does the media favor RDNT or AHCO?

Is RDNT or AHCO more profitable?

Do insiders and institutionals have more ownership in RDNT or AHCO?

Which has higher valuation and earnings, RDNT or AHCO?

Which has more risk & volatility, RDNT or AHCO?

Summary

How does AdaptHealth compare to Sotera Health?

Does the media favor SHC or AHCO?

Do insiders and institutionals have more ownership in SHC or AHCO?

Which has higher valuation and earnings, SHC or AHCO?

Do analysts rate SHC or AHCO?

Is SHC or AHCO more profitable?

Which has more risk & volatility, SHC or AHCO?

Summary

How does AdaptHealth compare to Billiontoone?

Do analysts recommend BLLN or AHCO?

Is BLLN or AHCO more profitable?

Do institutionals & insiders hold more shares of BLLN or AHCO?

Which has higher valuation and earnings, BLLN or AHCO?

Does the media prefer BLLN or AHCO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools